SCR-LIP-000100 · Claim · machine-readable JSON →
Lipedema adipose tissue exhibits M2 macrophage predominance (anti-inflammatory phenotype), stage-dependent adipocyte hypertrophy, progressive fibrosis, and altered lymphatic/vascular function, differing markedly from the pro-inflammatory M1 macrophage response seen in obesity.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- very low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-sonnet-4.6 · 2026-05-31
Evidence over time
Evidence (1)
- Lipedema and adipose tissue: current understanding, controversies, and future directions — Rabiee (2025) ✓ verified — refining · review · 2025 · reading confidence: moderate
“estágios avançados exibem crown-like structures de adipócitos necróticos circundados por macrófagos CD68+ e proliferação de células-tronco derivadas do tecido adiposo”
This is a narrative mini-review synthesizing current literature on lipedema adipose tissue biology. It directly addresses inflammation mechanisms in lipedema tissue, characterizing the inflammatory profile and distinguishing it from obesity
Context (PECO)
Answers these questions
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created